Immunocore Holdings - Stock Price History | IMCR

Historical daily share price chart and data for Immunocore Holdings since 2021 adjusted for splits. The latest closing stock price for Immunocore Holdings as of September 27, 2021 is 35.75.
  • The all-time high Immunocore Holdings stock closing price was 56.34 on February 08, 2021.
  • The Immunocore Holdings 52-week high stock price is 61.99, which is 73.4% above the current share price.
  • The Immunocore Holdings 52-week low stock price is 27.77, which is 22.3% below the current share price.
  • The average Immunocore Holdings stock price for the last 52 weeks is 38.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Immunocore Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.542B $0.039B
Immunocore Holdings plc is a late-stage biotechnology company. It engages in development of a novel class of T cell receptor bispecific immunotherapies designed to treat diseases, including cancer, infectious and autoimmune disease. Immunocore Holdings plc is based in Abingdon, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29